You are currently viewing a new version of our website. To view the old version click .
Pharmaceutics
  • Correction
  • Open Access

24 March 2025

Correction: Mokoena et al. Conjugation of Hypericin to Gold Nanoparticles for Enhancement of Photodynamic Therapy in MCF-7 Breast Cancer Cells. Pharmaceutics 2022, 14, 2212

,
and
Laser Research Centre, Faculty of Health Sciences, University of Johannesburg, P.O. Box 17011, Johannesburg 2028, South Africa
*
Author to whom correspondence should be addressed.

Error in Figure

In the original publication [1], there was a mistake in Figure 4 as published. Inadvertently, the wrong image was included for Mitotracker—8 h. The corrected Figure 4 appears below. The authors state that the scientific conclusions are unaffected. This correction has been approved by the Academic Editor. The original publication has also been updated.
Figure 4. Hyp-AuNP compound localization in MCF-7 cells showing Hyp-AuNP accumulation in the cytoplasm, lysosomes (lysotracker-green) and mitochondrion (mito-tracker-green) at 12 h, indicated by the orange color (mixture of green and red) (Hyp-AuNP). No significant Hyp-AuNP localization on the endoplasmic reticulum (ER tracker) was observed at any incubation time. Cell nuclei were counterstained with DAPI (blue).

Reference

  1. Mokoena, D.; George, B.P.; Abrahamse, H. Conjugation of Hypericin to Gold Nanoparticles for Enhancement of Photodynamic Therapy in MCF-7 Breast Cancer Cells. Pharmaceutics 2022, 14, 2212. [Google Scholar] [CrossRef] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Article Metrics

Citations

Article Access Statistics

Multiple requests from the same IP address are counted as one view.